|
Resolution: standard / high Figure 2.
Predicted versus known DOPA molar fraction. A-C) Comparison of the predictive performance of PLS-1 models constructed from either
pre-processed or unprocessed spectra from samples at 25°C. A) Model obtained after
smoothing and normalizing the full spectra, followed by a selection of a restricted
portion of wavelengths (434–590 nm, Fig. 1B). B) Model constructed with the raw and full spectra (354–590 nm, Fig. 1A). C) Model constructed with the smoothed, normalized and full spectra (354–590 nm).
Statistical parameters, reflecting the model's performance, are shown in each panel
(see text for details). Each model was tested by leave-one-out cross-validation. Since
the model shown in (A) displayed the highest predictive performance, it was used to
estimate the DOPA molar fraction in AChR-containing samples at 25°C. Models obtained
at 40°C (panel D) and 55°C (panel E) from pre-processed spectra. Bars represent deviation,
expressing the degree of similarity between the predicted samples and the calibration
samples used to build each model. Deviation (95% confidence interval around the predicted
value) is computed as a function of the sample's leverage and its x-residual variance.
After removing outliers, linear equations in each plot were computed using the remaining
numbers of AChR-free samples: 13 in (A), 14 in (B) and (C), 13 in (D) and 12 in (E).
Wenz and Barrantes PMC Biophysics 2008 1:6 doi:10.1186/1757-5036-1-6 |